Queensland University of Technology   Overview Biopharmaceuticals, agbiotech, medical devices and advanced diagnostics are the real world focus of Queensland University of Technology (QUT). QUT has a well-established and internationally recognised biotechnology capability consisting of several leading research programs:  Hormone Dependent Cancer  Infectious Diseases  Plant Biotechnology  Tissue BioRegeneration and Integration  Medical devices  Biofuels and fermentation products  Environmental biotechnology These programs are components of research activity within QUT's Faculties, two of its research Institutes - the Institute of Health and Biomedical Innovation and the Institute for Sustainable Resources - and its Centre for Tropical Crops and Biocommodities. With one of Australia’s longest records of successful biotechnology spin-outs, QUT has focused its commercialisation and development activities with the establishment of qutbluebox pty ltd (‘bluebox') as its commercialisation company. bluebox plays a central role in research management, is responsible for technology transfer management of QUT’s IP portfolio and commercialisation of research outcomes at QUT, and will facilitate interactions with commerce, industry and government. Business Opportunities (i.e Corporate Alliances/Partnerships) bluebox is interested in discussing licensing opportunities and/or R&D collaborations with industry partners with the view to translating QUT’s impressive research-based IP portfolio. Technology/Products and Services Description bluebox has a large IP portfolio covering technologies across multiple disciplines, including vaccinology, microbial genetics, agribioscience, orthopaedic devices, biomarker discovery and polymer and peptide chemistry. Competitive Advantages bluebox welcomes queries regarding the opportunities and unmet needs that a specific technology addresses. Website address: www.qutbluebox.com.au